Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.

ABSTRACT:

SUBMITTER: Wakelee HA 

PROVIDER: S-EPMC5789803 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature